The company’s first corporate brand campaign centers on a short film in which patients express gratitude to the clinicians and laboratory teams behind their diagnoses.
Werfen has launched “Thank You,” an initiative to recognize the health care professionals and laboratory teams who use in vitro diagnostics in clinical decision-making. The campaign coincides with the company’s 60th anniversary. It is Werfen’s first corporate brand campaign centered entirely on its purpose of advancing patient care by delivering trusted and innovative specialized diagnostics.
The centerpiece is a documentary short film, available at werfen.com/thankyou. It features real patients who have been through complex health processes. They thank the professionals who interpreted their test results and provided the clarity needed to determine the appropriate therapeutic path. Werfen says the film is meant to show the direct effect of reliable, timely data at diagnosis and during ongoing disease management.
According to Werfen, in vitro diagnostics influence around 70% of clinical decisions worldwide. These range from confirming compatibility in a kidney transplant to detecting chronic disease or monitoring patients during highly complex cardiac surgery. The company notes that this analytical work largely takes place behind the scenes.
Patient Stories Across Five Clinical Areas
Werfen developed the campaign in collaboration with patient associations and nonprofit organizations. It addresses the role of diagnostics in more than a dozen conditions, including lupus, thalassemia, hemophilia, thrombosis episodes, rheumatoid arthritis, complex cardiac surgery, and kidney and liver transplants. These conditions reflect Werfen’s five specialized clinical areas: hemostasis, acute care diagnostics, transfusion, autoimmunity, and transplant.
“Sixty years ago, Werfen was born with a calling to stand alongside healthcare professionals in moments that mark a before and after in patients’ lives. Our responsibility is to provide maximum analytical precision so that professionals can make decisions with total confidence when it matters most,” says Alejandro Risso, CEO of Werfen, in a release.
“Behind every diagnosis there is knowledge, experience, precision and, above all, people committed to improving and saving lives. With this campaign we want to bring these professionals to the forefront and thank them for a work that, after 60 years, continues to give meaning to ours,” Risso adds.
Six Decades in Specialized Diagnostics
Werfen was founded in Barcelona in 1966. It has since become a multinational group specialized in in vitro diagnostics, with a presence in more than 30 countries and its own research and development capacity and production centers in Europe and the United States.
The company expanded through direct commercial expansion in key markets such as the United States and China, along with the progressive integration of specialized firms in its clinical areas. That process culminated in a 2024 decision to concentrate all of its resources and research on in vitro diagnostics. In 2025, Werfen allocated 190 million euros to research and development.
Photo caption: Werfen’s “thank you” campaign image
Photo credit: Werfen